RJH: Covid Windfall Largely Priced In
We downgrade our recommendation to HOLD rating, from BUY, with new 2022E target price of Bt40.50, +14% from Bt35.50 previously, derived from...
154 Views
RJH: Resilient Performance Amidst Covid Situation
We maintain BUY rating with new 2022E target price of Bt35.50, from Bt29.00, derived from 30.0xPE, which is -1SD of SET Healthcare sector’s during...
165 Views
Record High Revenue Thanks to Covid-19 Diagnostics
We like RJH for it is one of the cheapest hospital stock in the sector. Meanwhile, it has an expansion plan of two hospitals in the pipeline.
169 Views
BCH: Positive Sentiment from New Rate Adjustment for SSO Patients
Yesterday's analyst meeting came out with a positive tone. We maintain our BUY rating with a target price of Bt21.0 based on DCF on the back of...
359 Views
RJH: Cheap with Growing Potential
We initiate coverage of RJH with a BUY rating and a 2020E target price of Bt32.00, derived from 27.4xPE’20E, which is the current average trading...
434 Views